logo

For the Inventor, By the Inventor

Canterbury, United Kingdom

David A Cox

This inventor holds 8 USPTO granted patents. Top assignees: Pfizer Corporation, Pfeizer Inc.. Active years: 1976-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Cox. Retrieved from https://idiyas.com/inventor/david-a-cox-0v9v56p5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 85(Granted Patents)


Location History:

  • Canterbury, EN (1976 - 1978)
  • Canterbury, GB (1978 - 1979)

Company Filing History:

goldMedal7 out of 4,488 
 
Pfizer Corporation
 patents
silverMedal1 out of 1 
 
Pfeizer Inc.
 patent

Years Active: 1976-1979

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4137328 - Phenyl-alkanolamine, alkylamine and .alpha.-aminoalkyl ketone (1979-01-30),
2. 4107314 - Antifungal thio-alkyl-imidazole derivatives (1978-08-15),
3. 4086272 - Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives (1978-04-25),
4. 4058610 - 7-D-(.alpha.-Acylamino-arylacetamido)-cephalosporanic acid derivatives (1977-11-15),
5. 4006230 - 7-D-(.alpha.-acylamino-arylacetamido)-cephalosporanic acid derivatives (1977-02-01),
6. 3976783 - Method of stimulating the heart employing ureido substituted (1976-08-24),
7. 3971783 - 4-Aminoquinazoline derivatives as cardiac stimulants (1976-07-27),
8. 3961072 - Phenoxypropanolamine therapeutic agents (1976-06-01),

Title: The Innovative Contributions of David A. Cox

Introduction

David A. Cox is a renowned inventor based in Canterbury, England, who has made significant contributions to the fields of pharmacology and medicinal chemistry. With a total of eight patents to his name, his work has paved the way for innovative therapeutic solutions.

Latest Patents

Among his latest patents are groundbreaking discoveries in the realm of heart stimulants and antifungal agents. One notable patent focuses on novel substituted 1-phenyl-2-alkylamino-alkanols, as well as 1-phenyl-2-alkylaminoalkanes and α-aminoalkyl phenyl ketones, which are recognized for their utility as heart stimulants. In another significant innovation, his patent for antifungal thio-alkyl-imidazole derivatives presents novel 1-aryl-2-(1-imidazolyl)-alkyl sulphides that exhibit promising anti-fungal properties.

Career Highlights

David A. Cox has held pivotal roles in esteemed pharmaceutical companies, including Pfizer Corporation and Pfeizer Inc. His work within these organizations has not only showcased his expertise but also furthered the development of effective medical treatments that address critical health challenges.

Collaborations

Throughout his career, Cox has collaborated with notable individuals, including Ian T. Barnish and Anthony G. Evans. These collaborations have fostered an environment of creativity and innovation, leading to advancements in therapeutic research and development.

Conclusion

David A. Cox’s work exemplifies the spirit of innovation and dedication to improving health outcomes through scientific research. His patents reflect a commitment to advancing medical science, making him a key figure in the field of inventive solutions for complex health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…